SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908834-24-000053
Filing Date
2024-02-12
Accepted
2024-02-12 17:11:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 rvmd_13ga.htm SC 13G/A 481381
  Complete submission text file 0000908834-24-000053.txt   483142
Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

IRS No.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91387 | Film No.: 24621179
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)